Assessment of resveratrol bioavailability in the perfused small intestine of the rat

Drugs under Experimental and Clinical Research

Volumn 26, Issue 2, 2000, Pages 47-55

  Andlauer, Wilfried ^a   Kolb, J ^a   Siebert, K ^a   Furst P ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROCARBON; LACTIC ACID; PYRUVIC ACID; RESVERATROL;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG GLUCURONIDATION; DRUG METABOLISM; INTESTINE PERFUSION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; OXYGEN CONSUMPTION; RAT; SMALL INTESTINE; SMALL INTESTINE ABSORPTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; INTESTINE, SMALL; MALE; MASS SPECTROMETRY; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SOLVENTS; STILBENES;

EID: 0034119783     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Goldberg D.M., Yan J., Ng E., et al. A global survey of transresveratrol concentrations in commercial wines. Am. J. Enol. Vitic., 46, 165, 1995.
2. Sobolev V.S., Cole R.J., Dorner J.W., Yagen B. isolation, purification, and liquid chromatographic determination of stilbene phytoalexins in peanuts. J. A.O.A.C Int., 78, 1182, 1995.
3. Bavaresco L., Fregoni C., Cantu E., Trevisan M. Stiibene compounds: From the grapevine to wine Drugs Exptl. Clin. Res., 25, 57, 1999.
4. Mattivi F., Reniero F., Korhammer S. Isolation, characterization, and evolution in red wine vinification of resveratrol monomers. J. Agric. Food Chem., 43, 1820, 1995.
5. Sato M., Suzuki Y., Okuda T., Yokotsuka K. Contents of resveratrol, piceid, and their isomers in commercially available wines made from grapes cultivated in Japan. Biosci. Biotechnol. Biochem., 61, 1800, 1997,
6. Schultz T.P., Boldin W.D., Fisher T.H., Nicholas D.D., McMurtrey K.D., Pobanz K. Structure-fungicidal properties of some 3-and 4-hydroxylated stilbenes and bibenzyl analogues. Phytochemistry, 31, 3801, 1992.
7. Jang M., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Drugs Exptl. Clin. Res., 25, 65, 1999.
8. Lu R., Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J. Cell Physiol., 179, 297, 1999.
9. Carbo N., Costelli P., Baccino F.M., Lopez-Soriano F.J., Argiles J.M. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun., 254, 739, 1999.
10. Soleas G.J., Tomlinson G., Diamandis E.P., Goldberg D.M. Relative contributions of polyphenolic constituents to the antioxidant status of wines - development of a predictive model. J. Agric. Food Chem., 45, 3995, 1997.
11. Miller N.J., Rice-Evans C.A. Antioxidant activity of resveratrol in red wine [letter]. Clin. Chem., 41, 1789, 1995.
12. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL oxidation by resveratrol [letter]. Lancet, 341, 1103, 1993.
13. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the "French paradox"? Eur. J. Endocrinol., 138, 619, 1998.
14. Jäger U., Nguyen-Duong H. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneimittelforschung., 49, 207, 1999.
15. Das D.K., Sato M., Ray P.S., et al. Cardioprotection of red wine: Role of polyphenolic antioxidants. Drugs Exptl. Clin. Res., 25, 115, 1999.
16. Pace Asciak C.R., Rounova O., Hahn S.E., Diamandis E.P., Goldberg D.M. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta, 246, 163, 1996.
17. Bertelli A.A., Giovannini L., Giannessi D., et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tissue React., 17, 1, 1995.
18. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: A molecule whose time has come? And gone? Clin. Biochem., 30, 91, 1997.
19. Bertelli A., Bertelli A.A., Gozzini A., Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exptl. Clin. Res., 24, 133, 1998.
20. Bertelli A.A., Giovannini L., Stradi R., Urien S., Tillement J.P., Bertelli A. Kinetics of trans-and cis-resveratrol (3,4′,5-trihydroxystilbene) after red wine oral administration in rats. Int. J. Clin. Pharmacol. Res., 16, 77, 1996.
21. Bertelli A.A., Giovannini L., Stradi R., Bertelli A., Tillement J.P. Plasma, urine and tissue levels of trans-and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tissue React., 18, 67, 1996.
22. Bertelli A.A., Giovannini L., Stradi R., Urien S., Tillement J.P., Bertelli A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exptl. Clin. Res., 24, 51, 1998.
23. Hummel M., Pogan K., Stehle P., Fürst P. Intestinal taurine availability from synthetic amino acid-taurine conjugates: An in vitro perfusion study in rats. Clin. Nutr., 16, 137, 1997.
24. Pauth M., Raible A., Bauder-Gross D., Vieillard-Baron D., Fürst P., Hartmann F. Effects of dexamethasone on giutamine metabolism in the isolated vascularly perfused rat small intestine. Res. Exptl. Med., 191, 349, 1991.
25. Hartmann F., Vieillard-Baron D., Heinrich R. Isolated perfusion of the small intestine using perfluorotributylamine as artificial oxygen carrier. Adv. Exp. Med. Biol., 180, 711, 1984.
26. Sfakianos J., Coward L., Kirk M., Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr., 127, 1260, 1997.
27. Sanders T., McMichael R.W. Presentation at the American Chemical Society Annual Meeting, Las Vegas, Nevada, 1997.
28. Mattivi F. Solid phase extraction of trans-resveratrol from wines for HPLC analysis. Z. Lehensm. Unters. Forsch., 196, 522, 1993.
29. Plauth M., Kremer I., Raible A., Stehle P., Fürst P., Hartmann F. Nitrogen absorption from isonitrogenous solutions of L-leucyl-L-leucine and L-leucine: A study in the isolated perfused rat small intestine. Clin. Sci., 82, 283, 1992.
30. Hummel M. "Perfusionsstudien zur Verwertung von Taurinkonjugaten am Dünndarm der Ratte". Doctoral Thesis, University of Hohenheim, Dr. Köster Verlag, Berlin, 1998.
31. Juan M.E., Lamuela-Raventos R.M., Planas J.M. Determination of trans-resveratrol in plasma by HPLC. Ann. Chem., 71, 747, 1999.
32. Lauterbach F., Czekay R.P., Sund R.B. Compartmentation cf intestinal drug sulphoconjugation. Incorporation of luminal and contraluminal [S]-sulphate into 1-naphthol by the isolated mucosa of guinea pig jejunum and colon. Biochem. Pharmacol., 46, 1339, 1993.
33. Dutton G.J. "Glucuronidation of Drugs and Other Compounds". CRC Press Inc., Boca Raton, Florida. 1980.
34. De Vries M.H., Hofman A., Koster A.S.J., Noordhoek J. Systematic intestinal metabolism of 1-naphthol. A study in the isolated vascularly perfused rat small intestine. Drug Metabol. Dispos., 17, 573, 1989.
35. Koster A.S.J., Noordhoek J. Glucuronidation in isolated perfused rat intestinal segments after mucosal and serosal administration of 1-naphthol. J. Pharmacol. Exp. Ther., 226, 533, 1983.
36. Walle U.K., Galijatovic A., Walle T. Transport of the fiavonoid chrysin and its conjugated metabolites by the human intestinal ceil line Caco 2. Biochem. Pharmacol., 58, 431, 1999.
37. Rafiei A., Bojcsev S., Fischer, E. Dose-dependent intestinal and hepatic glucuronidation and sulfatation of p-nitrophenol in the rat. Ada Physiol. Hung., 84, 333, 1996.
38. Fischer E., Rafiel A., Bojcsev S. Intestinal elimination of p-nitrophenol in the rat. Acta Physiol. Hung., 83, 355, 1995.